AXIOS May 16, 2023
By Ashley Gold

Lawmakers aired fears Tuesday about the potential misuse of generative AI, peppering OpenAI CEO Sam Altman with questions as he repeatedly said he’d welcome legislation in the space.

Driving the news: OpenAI’s generative AI product ChatGPT sparked the latest AI craze. The likelihood that lawmakers will unite and act on AI regulation, before the technology rapidly develops, remains slim.

Our thought bubble: Altman, testifying in Congress two weeks after his appearance at a White House AI summit, was thoughtful and exacting in his responses to senators, even when members got a little combative.

  • He struck a balance...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Congress / White House, Govt Agencies, Regulations, Technology
Navigating the world of artificial intelligence in health care
Cohere just launched ‘North,’ its biggest AI bet yet for privacy-focused enterprises
AI's Role in Oncology: Supporting, Not Replacing, Health Care Providers
Unlocking peak operational performance in clinical development with artificial intelligence
Boosting biopharma R&D performance with a next-generation technology stack

Share This Article